Quoin Pharmaceuticals, Ltd. (QNRX)
Develops skin creams and treatments for rare genetic and connective tissue disorders.
$4.20-0.02%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago-38.4%
The outlook
QNRX is trading near its 52-week lows with analyst consensus rated Strong Buy and an average price target about 410% above the current price. The stock sits well below both its 50- and 200-day moving averages, reflecting a weak recent trend despite the bullish analyst view.
What’s behind the score
Analyst consensusStrong Buy — 1.3 avg of 5 analysts
Price trendBelow its 50- & 200-day averages
52-week range2% of the way from its 52-week low to high
Price targetAvg target +410% vs current price
Analyst price target
~12-month · 5 analysts$21.40average target+409.5% vs now
Now $4.20
Low $12.00High $35.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$8.4M
52-wk high
$41.80
52-wk low
$3.25
50-day avg
$4.57
200-day avg
$8.98
Trailing P/E
—